As it is so crucial to understand how to limit inflammation in the response to SARS-CoV-2, we targeted immunoregulatory cytokines transforming growth factor β (TGF-β), IL-10, and IL-4 to assess their roles in pathology in maSARS-CoV-2 infection. This evidence concerns the gene TGFB1 and COVID-19.